Structure-Based Virtual Screening Identifies Ritobegron and Resveratrol as Dual Inhibitors of NMDA and PTP-1B for Alzheimer’s Disease Therapy · Peerford
Article · Journal · 2026
Structure-Based Virtual Screening Identifies Ritobegron and Resveratrol as Dual Inhibitors of NMDA and PTP-1B for Alzheimer’s Disease Therapy